Advanced Filters
noise

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 3,186 clinical trials
A Audrey BARZIC, Dr

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.

- 18 years of age All Phase N/A
H Heather Hathorne

Video Telehealth Exercise Training in Cystic Fibrosis

The purpose of this research study is to begin an exercise program for patients with a cystic fibrosis (CF) exacerbation.

19 years of age All Phase N/A

A Phase 1, First-in-human Study of VX-828

The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 in healthy participants.

18 - 55 years of age All Phase 1

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis

This is a 3-part, single-ascending dose Phase 1a randomized, double-blind, placebo-controlled study in healthy volunteers (Part A) and multiple-ascending dose Phase 1a randomized, double-blind, placebo-controlled study in healthy volunteers (Part B), and a Phase 1b open-label study in subjects with CF (Part C) to assess the safety, tolerability, PK, and …

16 years of age All Phase 1

Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in Urine After a Short Pause of Therapy

In cystic fibrosis (CF) renal base excretion is impaired, due to mutations in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene, since CFTR function is crucial in regulation of the kidney's HCO3- excretion. The investigators suggest that challenged urine HCO3- excretion is a biomarker of CFTR function, which can be used …

18 years of age All Phase N/A
H Heather Hathorne

Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis

The purpose of this protocol is to begin an exercise program combined with behavioral counseling for patients who are hospitalized with a cystic fibrosis exacerbation. The exercise program will begin during the hospital stay. Beginning an exercise program during this period of reduced mobility and isolation may be an ideal …

18 years of age All Phase N/A
J John Brewington

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials

The purpose of this study is to validate and utilize a personalized medicine approach to identify potential treatments with current FDA approved CFTR modifiers for non-approved CF gene mutations. The study will perform ex vivo testing of CFTR function and current marketed CFTR modulating drugs on expanded nasal cells at …

6 years of age All Phase N/A
S SERMET Isabelle, Professor

Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients

The purpose of this study is to determine which biological marker, or association of biological markers, best predict clinical response of cystic fibrosis patients to CFTR modulators.

years of age All Phase N/A
T Tanicia Daley, MD

A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis

The goal of this study is to determine the extent to which excess dietary simple sugars serve as a secondary mediating factor in Cystic fibrosis-related diabetes (CFRD) development. The main questions it aims to answer are: Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial changes in glucose …

12 - 21 years of age All Phase N/A

A Phase 1 Study Evaluating Safety and Tolerability of RCT2100 in Healthy Participants

This is the first-in-human study with RCT2100 and is designed to provide safety and tolerability data for future clinical studies.

18 - 55 years of age All Phase 1

Simplify language using AI